Key metrics and charts across all fundamental categories.
Stock price and market valuation
CVS trades at $101.57, a 49.9% increase year-over-year. Market capitalization stands at $129.30B, up 51.3% from the prior year. Track CVS price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$407.90B in TTM revenue grew 7.6% YoY, reaching $100.43B last quarter. TTM EBITDA of $10.53B on operating income of $4.68B shows growth is flowing through. Net income of $2.93B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $252.97B in assets and $60.53B in long-term debt, the D/E of 0.8 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 44.1x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 0.3x and P/B of 1.7x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 4.7% is up 1.1% YoY — cost efficiency is improving. Net margin at 2.9% and gross margin of 44.8%. ROE of 3.8% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $3.40B on $4.25B in operating cash flow. The FCF / Net Income ratio of 1.2x means earnings are well backed by actual cash — high-quality earnings. Cash reserves of $9.54B provide financial flexibility. Share count is stable — no dilution or buyback activity.
